¹⁸F-NaF PET/MRI for Detection of Carotid Atheroma in Acute Neurovascular Syndrome.

Abstract

Background MRI and fluorine 18-labeled sodium fluoride (¹⁸F-NaF) PET can be used to identify features of plaque instability, rupture, and disease activity, but large studies have not been performed. Purpose To evaluate the association between ¹⁸F-NaF activity and culprit carotid plaque in acute neurovascular syndrome. Materials and Methods In this prospective observational cohort study (October 2017 to January 2020), participants underwent ¹⁸F-NaF PET/MRI. An experienced clinician determined the culprit carotid artery based on symptoms and record review. ¹⁸F-NaF uptake was quantified using standardized uptake values and tissue-to-background ratios. Statistical significance was assessed with the Welch, χ², Wilcoxon, or Fisher test. Multivariable models were used to evaluate the relationship between the imaging markers and the culprit versus nonculprit vessel. Results A total of 110 participants were evaluated (mean age, 68 years ± 10 [SD]; 70 men and 40 women). Of the 110, 34 (32%) had prior cerebrovascular disease, and 26 (24%) presented with amaurosis fugax, 54 (49%) with transient ischemic attack, and 30 (27%) with stroke. Compared with nonculprit carotids, culprit carotids had greater stenoses (≥50% stenosis: 30% vs 15% [<i>P</i> = .02]; ≥70% stenosis: 25% vs 4.5% [<i>P</i> < .001]) and had increased prevalence of MRI-derived adverse plaque features, including intraplaque hemorrhage (42% vs 23%; <i>P</i> = .004), necrotic core (36% vs 18%; <i>P</i> = .004), thrombus (7.3% vs 0%; <i>P</i> = .01), ulceration (18% vs 3.6%; <i>P</i> = .001), and higher ¹⁸F-NaF uptake (maximum tissue-to-background ratio, 1.38 [IQR, 1.12-1.82] vs 1.26 [IQR, 0.99-1.66], respectively; <i>P</i> = .04). Higher ¹⁸F-NaF uptake was positively associated with necrosis, intraplaque hemorrhage, ulceration, and calcification and inversely associated with fibrosis (<i>P</i> = .04 to <i>P</i> < .001). In multivariable analysis, carotid stenosis at or over 70% (odds ratio, 5.72 [95% CI: 2.2, 18]) and MRI-derived adverse plaque characteristics (odds ratio, 2.16 [95% CI: 1.2, 3.9]) were both associated with the culprit versus nonculprit carotid vessel. Conclusion Fluorine 18-labeled sodium fluoride PET/MRI characteristics were associated with the culprit carotid vessel in study participants with acute neurovascular syndrome. Clinical trial registration no. NCT03215550 and NCT03215563 © RSNA, 2022 <i>Online supplemental material is available for this article.</i>